Friday, February 22, 2008


Medicine Man (film)

Jump to: navigation, search
Medicine Man
original movie poster

Directed by
John McTiernan

Produced by
Donna DubrowAndrew G. VajnaSean Connery

Written by
Tom SchulmanSally Robinson

Starring
Sean ConneryLorraine BraccoJosé Wilker

Music by
Jerry Goldsmith

Cinematography
Donald McAlpine

Distributed by
Hollywood PicturesCinergi Pictures

Release date(s)
1992

Running time
106 min.

Budget
$40 million

IMDb profile
Medicine Man is an American film, released in 1992 and directed by John McTiernan. It features Sean Connery as Dr. Robert Campbell, a researcher who ventures deep into the Amazon tropical rainforest searching for new medicines on behalf of a pharmaceutical company.
[edit] Summary
After a period of no communication the sponsoring pharmaceutical company receive a request for an additional research assistant and a gas chromatograph (GC). Believing Campbell and his research have gone 'off the rails' the company decide to send female researcher Dr Rae Crane (Lorraine Bracco) to convince him to abandon his research and return. When she arrives he is displeased. He had been expecting help but assumed it would be a friend and colleague of his. After an initial period of icy interaction they eventually warm up. When Crane presses Campbell to find out what he has been researching the past few months, he angrily demonstrates his results, and she is, appropriately, shocked: Campbell has managed to completely reduce malignant neoplasms in a native child (a cure for cancer) using an extract from a local plant. Even more shocking is Campbell's revelation that his oncological remedy has only been synthesized once and, despite his best efforts, he cannot seem to replicate the original chemical recipe. This ties into the scientific method through designing and controlling an experiment. Although their initial stock is running dangerously low, Campbell has tracked down one mysterious, elusive element, and with Crane's help, is determined to find it.
The main drama comes from the tension with a nearby logging company, who doesn't believe that Campbell's research is important enough to merit the salvation of the forest. Campbell is also explicit about not sharing his research, for fear of being unable to find the missing element in time before other, more well-funded researchers storm through the area -- thus destroying the lives of the indigenous people who live there.
Eventually, Crane and Campbell discover that the missing element is the presence of a rare kind of ant that often uses the flower (the main source of the cure) for food and habitation (the ants were often washed away during the preparation of the flowers for chemical analysis). The discovery is purely by accident. After testing several samples, Dr. Crane runs a calibration test on the G.C. Since she has run out of calibration samples, she creates a sugar-based test serum as a substitute, unaware that the same rare ants had invaded her sugar bowl. The ants go in with the sugar solution, and the sample comes up positive, a match for the original flower sample that had the healing properties.
However, their revelation comes too late. The logging company comes plowing through the forest, building a road straight through the area of Dr. Campbell's research. There is an accident, and a bulldozer catches fire. The fire quickly spreads through the forest, burning up the village and the research post along with many acres of rainforests.
The final scene features a voice-over narration by Crane to her fiancee, informing him that she will accompany Campbell on his searches even deeper into the forest.

[edit] Trivia
Sean Connery based his hairstyle upon that of the film's composer, Jerry Goldsmith, whom Connery was friends with. Goldsmith is even jokingly-listed in the end credits as one of Connery's hairstylists.
Early in the film Campbell (Sean Connery) tells Crane (Lorraine Bracco) he was planning to call her 'Brooklyn' to which Crane replies 'I'm from the Bronx'. In real life Bracco is from Brooklyn.

This 1990s drama film-related article is a stub.
New medicines
Jump to: navigation, search
New Medicines

Studio album by Dead Poetic
Released
April 6, 2004
Recorded
September 29-November 2, 2003, Compound Studios, Seattle, Washington
Genre
Post-Hardcore
Length
48:23
Label
SolidState Records / Tooth & Nail Records
Producer
Aaron Sprinkle
Professional reviews
All Music Guide link
Jesus Freak Hideout link
Dead Poetic chronology
Four Wall Blackmail(2002)
New Medicines(2004)
Vices(2006)
New Medicines is Dead Poetic's second full length CD, released in 2004 through SolidState Records and Tooth & Nail Records. This is the first (and only) of their CDs to feature second guitarist Todd Osborn. The album takes a different path than a lot of other albums produced by bands in their genre. The lyrics in songs such as "The Dream Club Murders" and "Glass In The Trees" are very focused on the death of someone, whether literal or metaphorical, which is something not commonly found in songs. After this album, the band decided that they didn't want to have anymore screaming vocals and go on a more of a rock & roll path to divert from the "screamo" sound. Their latest release, titled "Vices", showcases their newer sound.
Contents[hide]
1 Track listing
2 Writing Credits
3 Personnel
4 External links


[edit] Track listing
"Taste The Red Hands" – 2:58
"The Dream Club Murders" – 3:49
"New Medicines" – 4:01
"Vanus Empty" – 3:55
"Bury The Difference" – 3:33
"Molotov" – 3:46
"Glass In The Trees" – 5:01
"Dimmer Light" – 4:06
"Hostages" – 3:22
"Modern Morbid Prophecies" – 3:52
"A Hoax To Live For" – 10:08 (Song Ends at 2:52)
"Zonshine" (Hidden- Starts at 4:
Essential medicines

Jump to: navigation, search
Essential medicines, as defined by the World Health Organization are "those drugs that satisfy the health care needs of the majority of the population; they should therefore be available at all times in adequate amounts and in appropriate dosage forms, at a price the community can afford."
The WHO has published a model list of essential medicines. Each country is encouraged to prepare their own lists taking into consideration local priorities. At present over 150 countries have published an official essential medicines list. The WHO List contains a core list and a complementary list.
The core list presents a list of minimum medicine needs for a basic health care system, listing the most efficacious, safe and cost-effective medicines for priority conditions. Priority conditions are selected on the basis of current and estimated future public health relevance, and potential for safe and cost-effective treatment.
The complementary list presents essential medicines for priority diseases, for which specialized diagnostic or monitoring facilities are needed. In case of doubt medicines may also be listed as complementary on the basis of consistent higher costs or less attractive cost-effectiveness in a variety of settings.
The compilation of an essential medicines list enables health authorities, especially in developing countries, to optimize pharmaceutical resources.
The list is important because:
it forms the basis of national drugs policy in many countries, both developed and developing (e.g. South Africa, Eritrea).
governments refer to WHO recommendations when making decisions on health spending.
Contents[hide]
1 Essential medicines: theory and practice
2 Sections
3 Cost-to-benefit ratio
4 Number of drugs
5 See also
6 External links


[edit] Essential medicines: theory and practice
The original 1977 WHO definition of “essential medicines” was that they were ‘of utmost importance, basic, indispensable, and necessary for the healthcare needs of the population’.[1] The concept was mentioned in one of the ten points of the 1978 Alma Ata Declaration on primary health care.
The difficulty of putting this into practice is reflected in the rather longer and more categorical 2002 definition:
‘Essential medicines are those that satisfy the priority health care needs of the population. They are selected with due regard to public health relevance, evidence on efficacy and safety, and comparative cost-effectiveness. Essential medicines are intended to be available within the context of functioning health systems at all times in adequate amounts, in the appropriate dosage forms, with assured quality and adequate information, and at a price the individual and the community can afford. The implementation of the concept of essential medicines is intended to be flexible and adaptable to many different situations; exactly which medicines are regarded as essential remains a national responsibility.’[2]
The WHO Model List of Essential Medicines has been updated every two years since 1977. The current version, the 15th list, dates from March 2007.

[edit] Sections
The constituents of the list remain controversial. The list is divided into two sections:
Core medicines that are efficacious, safe, and cost effective medicines for priority conditions.
Medicines that are efficacious, safe and cost effective, but that are not necessarily affordable, or for which specialized healthcare services are required.

[edit] Cost-to-benefit ratio
Cost effectiveness is difficult to define and is the subject of fierce debate between producers (pharmaceutical companies) and purchasers of drugs (national health services).

[edit] Number of drugs
The number of drugs has nearly doubled, from 186 in 1977 to 320 in 2002. The range has increased substantially over the years and now includes antimigraine drugs, antidotes, and antineoplastic drugs.

[edit] See also
World Health Organization
Department of Essential Drugs and Medicines
Campaign for Access to Essential Medicines
Universities Allied for Essential Medicines

[edit] External links
WHO Model List of Essential Medicines (2007)
WHO Model List of Essential Medicines

Categories: World Health Organization Pharmacy

Friday, January 25, 2008

THIS is the mother of two who died after being stabbed in the heart several times in south London. Tracy Ann Meade, 39, from South Norwood, was killed in front of a row of garages in Warminster Road at about 10.50pm on ...



Heart attack victims wait too long to seek help
From: The Milwaukee Journal Sentinel Date: July 12, 2004 Author: STEPHEN SMITH More results for: heart attack Copyright information Copyright 2004 The Milwaukee Journal Sentinel. This material is published under license from the publisher through ProQuest Information and Learning Company, Ann Arbor, Michigan. All inquiries regarding rights should be directed to ProQuest Information and Learning Company.

Heart attack victims wait too long to seek help

By STEPHEN SMITH Boston Globe

Monday, July 12, 2004

They call it the Hollywood heart attack: Perry Mason bores into an unsuspecting witness, accusations gathering like storm clouds. Then suddenly, the witness clutches his chest, torso quaking, face etched in pain.

"A lot of people wait for the classic signs and symptoms of a heart attack, like they see on TV, before they make that call for help," said Robert Goldberg, an epidemiologist at the University of Massachusetts Medical School.

Waiting can prove deadly.

Even as tremendous strides have been made in cardiology -- with tiny balloons clearing blockages and stainless steel scaffolds opening ...